🔎 Trials Near Me

Home › Glioblastoma › Colorado

Pag-aaral pangklinika para sa Glioblastoma sa Colorado

14 pag-aaral para sa Glioblastoma ang naghahanap ng mga kalahok sa mga site sa Colorado.

Mga Lungsod sa Colorado

Opisyal na teksto ng pag-aaral (English)

Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous Treatment

  • UCHealth University of Colorado Hospital, Aurora
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT05432804

A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma

  • University of Colorado Denver, Aurora
Nagre-recruitPhase 2/3
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT03970447

Sonocloud-9 in Association With Carboplatin Versus Standard-of-Care Chemotherapies (CCNU or TMZ) in Recurrent GBM

  • UCHealth, Aurora
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 29, 2026 · NCT05902169

A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations

  • Children's Hospital Colorado - Anschutz Medical Campus, Aurora
Nagre-recruitPhase 1/2
Hanggang edad 25 · Lahat ng kasarian · Na-update Set 25, 2026 · NCT04094610

Temporally-Modulated Pulsed Radiation Therapy Versus Standard Radiation Therapy for the Treatment of Newly Diagnosed, IDH Wildtype, MGMT-Unmethylated Glioblastoma

  • Saint Mary's Hospital and Regional Medical Center, Grand Junction
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 10, 2026 · NCT07452458

A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors

  • UCHealth Cancer Center - Anschutz Medical Campus - University of Colorado Cancer Center, Aurora
  • Sarah Cannon Research Institute at HCA HealthONE Presbyterian St. Luke's, Denver
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 10, 2026 · NCT06914128

Targeted Pediatric High-Grade Glioma Therapy

  • Children's Hospital Colorado, Aurora
Nagre-recruitObservasyonal na pag-aaral
12 Months – 39 Years · Lahat ng kasarian · Na-update Set 8, 2026 · NCT05839379

Study of Olutasidenib and Temozolomide in HGG

  • Children's Hospital Colorado, Aurora
Nagre-recruitPhase 2
Edad 12 hanggang 39 · Lahat ng kasarian · Na-update Set 1, 2026 · NCT06161974

SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)

  • University of Colorado Health Cancer Care, Aurora
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 28, 2026 · NCT05303519

Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion

  • Children's Hospital Colorado, Aurora
Nagre-recruitMaagang Phase 1Malugod na tinatanggap ang malusog na boluntaryo
Edad 1 hanggang 21 · Lahat ng kasarian · Na-update Hun 29, 2026 · NCT06333899

A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies

  • Sarah Cannon, SCRI Oncology Partners - Health One, Denver
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Hun 23, 2026 · NCT04678648

The EASE Study: Randomized Trial of a Novel Approach to Addressing Fear of Progression in Advanced Cancer

  • University of Colorado Anschutz Medical Campus, Aurora
  • University of Colorado Boulder, Boulder
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Hun 9, 2026 · NCT07636200

Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant

  • Children's Hospital Colorado, Aurora
Nagre-recruitPhase 2
12 Months – 39 Years · Lahat ng kasarian · Na-update May 29, 2026 · NCT05843253

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, Aurora
  • Massive Bio SYNERGY-AI site, Denver
  • Massive Bio SYNERGY-AI site, Littleton
Nagre-recruitObservasyonal na pag-aaral
Lahat ng edad · Lahat ng kasarian · Na-update Okt 28, 2025 · NCT03452774

Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.